Want to join the conversation?
In relation to the commercialization of reduced-risk products (RRPs), $PM has announced an investment of up to EUR500MM over three years in its first manufacturing facility in European Union and an associated pilot plant in Italy to produce RRPs. When fully operational by 2016, $PM expect to reach an annual production capacity of up to 30Bil units.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?